Company intelligence / Profile preview

Citadel

Ownership: Private
Development stage: Other

Overview

Citadel Discovery operates a large-scale data generation platform leveraging DNA Encoded Library technology to create comprehensive datasets for human disease-relevant proteins. The goal is to enable AI/ML-driven drug discovery by addressing the industry’s challenge of data scarcity. The company provides commercial access to these datasets for pharma and biotech companies, while offering low-cost or open-source access for academic groups. It positions itself as an “honest broker” in the field due to its public benefit corporation status, focusing on enabling rather than directly competing in therapeutic development

Therapeutic areas: Other
Modalities: Small molecule
Industry: Drug Discovery Services

Beyond the preview

Go deeper on Citadel.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Citadel.

Explore the full profile